Asianet Newsable on MSN11d
Early Signs of Osteoporosis: How to protect your bones before it's too late
Osteoporosis is a medical condition in which new calcium deposits in bone tissue cannot keep up with old bone calcium removal ...
Osteoporosis Drugs Market Size is Expected to Reach USD 19.96 Billion by 2033, Growing at a CAGR of 3.3%: Straits Research
The global osteoporosis drugs market size was valued at USD 14.90 billion in 2024 and is projected to reach USD 15.39 billion ...
Opportunistic CT bone density screening improves osteoporosis screening rate
Implementing opportunistic computed tomography (CT) bone density screening could increase the osteoporosis screening rate, ...
Rheumatology Advisor1d
Denosumab Biosimilars Stoboclo, Osenvelt Get FDA Approval
The FDA has approved Stoboclo (denosumab-bmwo), a biosimilar to Prolia (denosumab), and Osenvelt (denosumab-bmwo), a biosimilar to Xgeva (denosumab).
Protect your bones, preserve your independence with fracture prevention
Since you can’t see your bones aging, you should be proactive about preventing osteoporosis. Atrium Health’s Fracture ...
Prevention on MSN12d
Can a Weighted Vest Help Increase Bone Density?
Regular exercise can help improve bone health, and in some cases, you’ll see increased benefits if you do your exercises ...
Healio12d
Baseline BMD T-score can help determine first-line therapy for women with osteoporosis
Women with osteoporosis have at least a 50% chance of reaching their target bone mineral density at 3 years if they have a ...
Medical Dialogues5d
Liver cirrhosis increases the risk of osteoporosis and fractures: BMC Study
A new study published in the journal of BMC Gasteroenterology found that patients with the liver cirrhosis had higher risk of ...
The American Journal of Managed Care8d
FDA Approves Denosumab Biosimilars Stoboclo and Osenvelt
The FDA approved Stoboclo and Osenvelt, denosumab biosimilars that could offer more affordable treatment options for ...
Osteoporosis Global Clinical Trials Market Review 2025: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End-Point Status
The "Osteoporosis_Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report provides an overview of Osteoporosis Clinical ...